Latest Breaking News On - Steven lucio - Page 1 : comparemela.com

Transcripts For CNBC Power Lunch 20170602

You might need some hardware to fix it. Lock it power lunch. The may melt up. All of them hitting highs yet again. All three on track for a second straight week of gains. And check out the days movers within the averages. Canada goose soaring almost 10 on its earnings beat. The apparel maker. 60 since the ipo in midmarch. Broadcom, its rallying. Beating estimates and giving an outlook. Heres what else is happening. Kkr raising more than 9 billion for its most asia fund. And sets a new record for the region. Goldman sachs under fire for buying bonds in venezuela. Now the wall street journal reporting that goldmans trade was not reviewed by top executives. And new yorks attorney general claiming that exxon mobil misled about how it accounts for the impact of Climate Change on the operations by using internal estimates that were different from its public estimates and statements. And speaking of Climate Change, big business, not happy with President Trumps decision to pull out of the Glob

Vizient conducts first Insight: Cell, Gene, and Specialty Pharmacy Symposium

Vizient to Share Insights on Biosimilars at Festival of Biologics

Humira biosimilar savings may face delays | Modern Healthcare

Humira biosimilars are expected to reduce annual pharmaceutical expenditures by $5 billion, but they may be delayed by rebate strategies.

Biosimilars to limit drug price increases in 2023, report shows

Pharmaceutical prices are expected to increase 3.26% in 2023, a steep decline from the 6% price inflation in 2017.